{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:10:11Z","timestamp":1792131011448,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"University College London Comprehensive Bio-medical Research Centre"},{"name":"Moorfields Biomedical Research Centre"},{"name":"Dutch MS Research Foundation"},{"name":"ERN-EYE"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.brainres.2017.08.012","type":"journal-article","created":{"date-parts":[[2017,8,18]],"date-time":"2017-08-18T06:13:55Z","timestamp":1503036835000},"page":"95-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Time is vision in recurrent optic neuritis"],"prefix":"10.1016","volume":"1673","author":[{"given":"Esther","family":"Osinga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bob","family":"van Oosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willemien","family":"de Vries-Knoppert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0344-9749","authenticated-orcid":false,"given":"Axel","family":"Petzold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2017.08.012_b0005","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM199207233270414","article-title":"Corticosteroids in the treatment of optic neuritis","volume":"327","author":"Achiron","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.brainres.2017.08.012_b0010","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1600-0404.2010.01416.x","article-title":"Neuromyelitis optica (NMO)\u2013an autoimmune disease of the central nervous system (CNS)","volume":"123","author":"Asgari","year":"2011","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.brainres.2017.08.012_b0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/brain\/awu335","article-title":"Vision and vision-related outcome measures in multiple sclerosis","volume":"138","author":"Balcer","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2017.08.012_b0020","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1136\/jnnp-2013-306902","article-title":"A dam for retrograde axonal degeneration in multiple sclerosis?","volume":"85","author":"Balk","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.brainres.2017.08.012_b0025","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0006-8993(96)01302-9","article-title":"A new mechanism of methylprednisolone and other corticosteroids action demonstrated in vitro: inhibition of a proteinase (calpain) prevents myelin and cytoskeletal protein degradation","volume":"748","author":"Banik","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2017.08.012_b0030","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","article-title":"A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis","volume":"326","author":"Beck","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.brainres.2017.08.012_b0035","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","article-title":"A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group","volume":"326","author":"Beck","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.brainres.2017.08.012_b0040","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1600-0404.2010.01388.x","article-title":"Bilateral and recurrent optic neuritis in multiple sclerosis","volume":"123","author":"Burman","year":"2011","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.brainres.2017.08.012_b0045","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1212\/WNL.0000000000002774","article-title":"The APOSTEL recommendations for reporting quantitative optical coherence tomography studies","volume":"86","author":"Cruz-Herranz","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2017.08.012_b0050","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1177\/1352458511431074","article-title":"The time course and phenotype of Uhthoff phenomenon following optic neuritis","volume":"18","author":"Fraser","year":"2012","journal-title":"Mult. Scler."},{"key":"10.1016\/j.brainres.2017.08.012_b0055","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/archopht.1991.01080120057025","article-title":"The clinical profile of optic neuritis: experience of the Optic Neuritis Treatment Trial","volume":"109","author":"Group and others","year":"1991","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.brainres.2017.08.012_b0060","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0140-6736(15)61137-0","article-title":"Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial","volume":"386","author":"Le Page","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.brainres.2017.08.012_b0065","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1600-0404.2006.00629.x","article-title":"Effect of the treatment with methylprednisolone on the cerebrospinal fluid and serum levels of CCL2 and CXCL10 chemokines in patients with active multiple sclerosis","volume":"114","author":"Moreira","year":"2006","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.brainres.2017.08.012_b0070","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM199207233270414","article-title":"Corticosteroids in the treatment of optic neuritis","volume":"327","author":"Moskopp","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.brainres.2017.08.012_b0075","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s00417-010-1344-7","article-title":"Early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis optica","volume":"248","author":"Nakamura","year":"2010","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.brainres.2017.08.012_b0080","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1755-3768.1975.tb01159.x","article-title":"Later course and prognosis of optic neuritis","volume":"53","author":"Nikoskelainen","year":"1975","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.brainres.2017.08.012_b0085","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/WCO.0000000000000418","article-title":"Neuroprotection and visual function after optic neuritis","volume":"30","author":"Petzold","year":"2017","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.brainres.2017.08.012_b0090","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S1474-4422(10)70168-X","article-title":"Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis","volume":"9","author":"Petzold","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.brainres.2017.08.012_b0095","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00415-013-6957-4","article-title":"Chronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reported","volume":"261","author":"Petzold","year":"2014","journal-title":"J. Neurol."},{"key":"10.1016\/j.brainres.2017.08.012_b0100","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1136\/jnnp.2003.017236","article-title":"Axonal degeneration and inflammation in acute optic neuritis","volume":"75","author":"Petzold","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.brainres.2017.08.012_b0105","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrneurol.2014.108","article-title":"The investigation of acute optic neuritis: a review and proposed protocol","volume":"10","author":"Petzold","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.brainres.2017.08.012_b0110","first-page":"815068","article-title":"Hyperacute corticosteroid treatment of optic neuritis at the onset of pain may prevent visual loss: a case series","volume":"2011","author":"Plant","year":"2011","journal-title":"Mult. Scler. Int."},{"key":"10.1016\/j.brainres.2017.08.012_b0115","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2017.08.012_b0120","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0006-8993(93)91760-P","article-title":"An in vitro study of the effects of methylprednisolone on lesioned and uninjured mammalian spinal neurons","volume":"605","author":"Rosenberg-Schaffer","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2017.08.012_b0125","first-page":"55","article-title":"How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions 1","volume":"21","author":"Sapolsky","year":"2000","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.brainres.2017.08.012_b0130","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.exer.2008.05.017","article-title":"Inflammatory demyelination induces axonal injury and retinal ganglion cell apoptosis in experimental optic neuritis","volume":"87","author":"Shindler","year":"2008","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.brainres.2017.08.012_b0135","doi-asserted-by":"crossref","first-page":"e34823","DOI":"10.1371\/journal.pone.0034823","article-title":"The OSCAR-IB consensus criteria for retinal OCT quality assessment","volume":"7","author":"Tewarie","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.brainres.2017.08.012_b0140","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2017.08.012_b0150","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0006-8993(99)01191-9","article-title":"Axonal cytoskeleton changes in experimental optic neuritis","volume":"824","author":"Zhu","year":"1999","journal-title":"Brain Res."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899317303487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899317303487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T08:57:09Z","timestamp":1535446629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899317303487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":29,"alternative-id":["S0006899317303487"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2017.08.012","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Time is vision in recurrent optic neuritis","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2017.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}